Serum calprotectin is increased in early axial spondyloarthritis with sacroiliitis and objective signs of inflammation: Results from the DESIR cohort

Xavier Romand (1, 2) , Marie-Hélène Paclet (3, 2) , Anaïs Courtier , Minh Vu Chuong Nguyen (2) , Daniel Wendling (4, 5) , Francis Berenbaum (6, 7) , Philippe Gaudin (1) , Athan Baillet (1, 2)

1 Service de Rhumatologie [CHU de Grenoble]
2 TIMC-GREPI - Groupe de Recherche et d’Étude du Processus Inflammatoire
3 CHUGA - Centre Hospitalier Universitaire [CHU Grenoble]
4 CHRU Besançon - Centre Hospitalier Régional Universitaire de Besançon
5 EPILAB - Epigénétique des infections virales et des maladies inflammatoires (UR 4266)
6 CRSA - Centre de Recherche Saint-Antoine
7 CHU Saint-Antoine [AP-HP]

No abstract available

Keywords: calprotectin; S100 proteins; spondyloarthritis; biomarker; structural damage

Domains: Rhumatology and musculoskeletal system

Xavier Romand, Marie-Hélène Paclet, Anaïs Courtier, Minh Vu Chuong Nguyen, Daniel Wendling, et al.. Serum calprotectin is increased in early axial spondyloarthritis with sacroiliitis and objective signs of inflammation: Results from the DESIR cohort. Joint Bone Spine, 2021, 88 (1), pp.105068. ⟨10.1016/j.jbspin.2020.08.003⟩. ⟨hal-03511725⟩